全球性行為感染傳染病（STD）檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球性行為感染（STI）檢測市場預計將從2025年的152.9億美元成長至2034年的333.1億美元，2026年至2034年的複合年成長率（CAGR）為9.04%。該市場正穩步成長，主要得益於人們對性健康的日益重視以及全球性行為感染盛行率的上升。早期發現和診斷在預防感染傳播方面發揮著至關重要的作用，從而推動了對性傳染感染檢測服務和診斷工具的需求。政府措施、公共衛生宣傳活動和教育計畫顯著提高了已開發國家和發展中國家的檢測率。

關鍵促進因素包括診斷技術的進步，例如快速檢測套組、即時檢測和分子診斷，這些技術能夠提供準確快速的檢測結果。家用檢測套組的日益普及也提高了個人檢測的便利性和隱私性，鼓勵更多人接受檢測。此外，醫療保健支出的成長和檢測設施的擴張也推動了全球市場的成長。

隨著診斷技術的不斷創新和數位化醫療解決方案的融合，市場前景依然強勁。遠端醫療和線上諮詢平台預計將在擴大檢測服務覆蓋範圍方面發揮重要作用。隨著公眾意識的提高和歧視的減少，性行為感染感染檢測市場預計將穩定成長，尤其是在新興經濟體。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球性行為感染傳染病（STD）檢測市場：依產品類型分類

• 市場分析、洞察與預測
• 裝置
• 試劑和試劑盒

第5章 全球性行為感染傳染病（STD）檢測市場：依應用領域分類

• 市場分析、洞察與預測
• 披衣菌感染
• 梅毒
• 生殖器皰疹
• 淋病
• 人類免疫力缺乏病毒
• 人類乳突病毒
• 其他

第6章 全球性行為感染傳染病（STD）檢測市場：依設施分類

• 市場分析、洞察與預測
• 臨床試驗
• 照護端

第7章 全球性行為感染傳染病（STD）檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷中心
• 其他

第8章 全球性行為感染傳染病（STD）檢測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：與性行為感染傳染病（STD）相關的全球公司概況

測試業

• 主要公司的市佔率分析
• 公司簡介
  • F. Hoffmann-La Roche 有限公司
  • 雅培
  • BD
  • Hologic Inc
  • 賽默飛世爾科技
  • BioMerieux Inc
  • Cepheid（Danaher Corporation）
  • Bio-Rad Laboratories Inc
  • DiaSorin SpA

The global sexually transmitted diseases (STD) testing market size is expected to reach USD 33.31 Billion in 2034 from USD 15.29 Billion in 2025, growing at a CAGR of 9.04 during 2026-2034.This market is witnessing steady growth due to increasing awareness about sexual health and the rising prevalence of sexually transmitted infections worldwide. Early detection and diagnosis play a crucial role in preventing the spread of infections, which is driving demand for STD testing services and diagnostic tools. Government initiatives, public health campaigns, and educational programs are significantly contributing to increased testing rates across both developed and developing regions.

Key drivers include advancements in diagnostic technologies such as rapid test kits, point-of-care testing, and molecular diagnostics that offer accurate and quick results. The growing adoption of home-based testing kits is also enhancing accessibility and privacy for individuals, encouraging more people to get tested. Additionally, increasing healthcare funding and the expansion of testing facilities are supporting market growth globally.

Future prospects for the market remain strong, with continued innovation in diagnostic technologies and increasing integration of digital healthcare solutions. Telemedicine and online consultation platforms are expected to play a key role in expanding access to testing services. As awareness continues to rise and stigma decreases, the STD testing market is expected to grow steadily, particularly in emerging economies.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents & Kits

By Application

• Chlamydia
• Syphilis
• Genital Herpes
• Gonorrhea
• Human Immunodeficiency Virus
• Human Papillomavirus
• Others

By Setting

• Laboratory Testing
• Point-of-Care

By End User

• Hospital & Clinics
• Diagnostic Centers
• Others

COMPANIES PROFILED

• F. Hoffmann-La Roche Ltd., Abbott, BD, Hologic Inc., Thermo Fisher Scientific Inc., bioMerieux Inc., Cepheid (Danaher Corporation), Bio-Rad Laboratories Inc., DiaSorin S.p.A.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Chlamydia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Syphilis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genital Herpes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Gonorrhea Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Human Immunodeficiency Virus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Human Papillomavirus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET: BY SETTING 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Setting
• 6.2. Laboratory Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Point-of-Care Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospital & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEXUALLY TRANSMITTED DISEASES (STD) TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Setting
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Setting
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Setting
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Setting
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Setting
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SEXUALLY TRANSMITTED DISEASES (STD)

TESTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 F. Hoffmann-La Roche Ltd
  • 10.2.2 Abbott
  • 10.2.3 BD
  • 10.2.4 Hologic Inc
  • 10.2.5 Thermo Fisher Scientific Inc
  • 10.2.6 BioMerieux Inc
  • 10.2.7 Cepheid (Danaher Corporation)
  • 10.2.8 Bio-Rad Laboratories Inc
  • 10.2.9 DiaSorin S.p.A